Anúncio
Anúncio
XENE
Xenon Pharmaceuticals Inc
44.50
USDPatrocinado
-0.32
-0.72%
02 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
44.50
0.00
+0.01%
Relatórios de Lucros XENE
Rácio de surpresa positiva
XENE separação 23 de 40 últimas estimativas.
57%
Próximo Relatório
Data do Próximo Relatório
25 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$1.21
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/+6.14%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/+44.05%
Xenon Pharmaceuticals Inc earnings per share and revenue
On 03 de nov. de 2025, XENE reported earnings of -1.14 USD per share (EPS) for Q3 25, beating the estimate of -1.17 USD, resulting in a 2.13% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -4.94% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 20 analistas forecast an EPS of -1.21 USD, with revenue projected to reach -- USD, implying an aumentar of 6.14% EPS, and aumentar of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Holdings Inc. Common Stock
Report Date
22 de dez. de 2025 Para Q4 25
Estimativa
-$0.57
Real
-$0.73
Surpresa
-25.95%
Outlook Therapeutics, Inc. Common Stock
Report Date
19 de dez. de 2025 Para Q4 25
Estimativa
-$0.25
Real
-$0.19
Surpresa
+26.47%
Citius Oncology, Inc. Common Stock
Report Date
23 de dez. de 2025 Para Q4 25
Estimativa
-$0.12
Real
-$0.06
Surpresa
+50.98%
FAQ
What were Xenon Pharmaceuticals Inc's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Xenon Pharmaceuticals Inc reported EPS of -$1.14, beating estimates by 2.13%, and revenue of $0.00, 0% as expectations.
How did the market react to Xenon Pharmaceuticals Inc's Q3 2025 earnings?
The stock price moved down -4.94%, changed from $41.12 before the earnings release to $39.09 the day after.
When is Xenon Pharmaceuticals Inc expected to report next?
The next earning report is scheduled for 25 de fev. de 2026.
What are the forecasts for Xenon Pharmaceuticals Inc's next earnings report?
Based on 20
analistas, Xenon Pharmaceuticals Inc is expected to report EPS of -$1.21 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio